Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2006
12/27/2006CN1886148A Selective inhibition of NF-kB activation by peptides designed to disrupt NEMO oligomerization
12/27/2006CN1886131A Composition and method for treating macular degeneration
12/27/2006CN1886128A Compositions and methods for treating burns
12/27/2006CN1884554A Eucaryotic expression vector for treating tumour transfer and its construct method
12/27/2006CN1884550A Novel subtype CaMKII alpha3 gene and clone method, expressed protein and uses
12/27/2006CN1884521A Method for finding novel gene and computer system platform using same and novel gene
12/27/2006CN1884503A Bamboo leaf SOD preparation and functionalized food containing bamboo leaf SOD
12/27/2006CN1883709A Bi-functional targeting antineoplastic polypeptide and application thereof
12/27/2006CN1883703A Serine protease inhibitor of Rana grahami, its gene and application
12/27/2006CN1883702A Medicine for treating deep erosive trauma with crust
12/27/2006CN1883701A Ciliary nerves nutrilite composition having long-time stability
12/27/2006CN1883700A Novel use of xCT protein and its encoding gene
12/27/2006CN1883536A Orally administered cervus and cucumis polypeptide composition and preparation method thereof
12/27/2006CN1883508A Anti-dust nasal cleanser
12/27/2006CN1883457A Lyophilized suspended powder injection and preparation method thereof
12/27/2006CN1292002C Arginine deacylase fusion protein, method for preparation and application
12/27/2006CN1292001C Nucleus factor-kB p50 subunit antagonist peptide, preparation and application thereof
12/27/2006CN1292000C Nucleus factor-kB p65 subunit combination peptide, preparation and application thereof
12/27/2006CN1291998C Ligand of NKG2D acceptor and use
12/27/2006CN1291757C Remedy for inflammatory bowel diseases
12/27/2006CN1291756C Blood cell production via activation of hemeglobin scavenger receptor
12/27/2006CN1291754C Localized anesthesia synergistic delay agent
12/27/2006CN1291718C Remedy for acute myocardial infarction
12/26/2006US7153955 Apparatus for use as diagnostic and therapeutic tool in gene therapy
12/26/2006US7153951 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives
12/26/2006US7153950 For diagnosis of/drugs for inflammatory bowel disease/asthma/ diabetes/arthritis/cirrhosis/skin disorders
12/26/2006US7153949 Nucleic acid encoding poly-zinc finger proteins with improved linkers
12/26/2006US7153947 Ixodes salivary anticomplement protein
12/26/2006US7153946 Molecular conjugates for use in treatment of cancer
12/26/2006US7153944 High affinity integrin polypeptides and uses thereof
12/26/2006US7153943 Derivatives of growth hormone and related proteins, and methods of use thereof
12/26/2006US7153942 Polypeptide for use in the treatment of inflammation, rheumatoid arritis, psoriasis, and diabetic retinopathy
12/26/2006US7153940 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
12/26/2006US7153938 Cross-linked apatite/collagen porous body containing self-organized apatite/collagen composite and its production method
12/26/2006US7153936 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
12/26/2006US7153935 Tumor suppressor gene
12/26/2006US7153933 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same
12/26/2006US7153932 Immunotoxins comprising ribosome-inactivating proteins
12/26/2006US7153930 Peptide transport
12/26/2006US7153847 Dipeptide-substituted benzo- and dibenzocaprolactams, which inhibit beta -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease
12/26/2006US7153841 Conjugates with carriers; red shifted absorption; antiproliferative and antitumor agents; benign prostatic hyperplasia; diagnosis
12/26/2006US7153836 Having 1-4 hydrophobic C 10-24 aliphatic, saturated or unsaturated hydrocarbon residue moieties covalently bound to a protein with a hedgehog N-terminal domain; includes auxiliary substances, detergents, stabilizers, matrix materials, suramin, heparin, anionic polysaccharides and/or sequestering agents
12/26/2006US7153835 Dipeptides and tripeptides for treating inflammatory reactions, including allergic reactions
12/26/2006US7153834 A homogeneous cyclosporin solution comprising a carrier dialkyl ester of aliphatic or aromatic dioic acid, hydrophilic lipophilic balance, forming emulsions in stomach with gastrointestinal fluids
12/26/2006US7153833 Therapeutic uses of SMR1 peptides
12/26/2006US7153832 Compositions of active Wnt protein
12/26/2006US7153831 Rabconnectin-3-binding protein
12/26/2006US7153830 Administering factor XIII systemically optionally in conjunction with activated thrombin.
12/26/2006US7153829 Preventing or reducing neurocognitive defects due to reperfusion injury and/or damage to the central nervous system, such as cerebral ischemia caused by various kinds of strokes, by administering a polypeptide inhibitor of plasma kallikrein, Ecallantide
12/26/2006US7153828 Use of heregulin as a growth factor
12/26/2006US7153827 Produced by recombinant techniques; stimulating angiogenesis for wound healing and for vascular tissue repair
12/26/2006US7153826 Cyclic peptide antibiotics including the loloatins are effective in the treatment of rosacea, particularly when administered in conjunction with an antibiotic such as metronidazole that is effective against anaerobic bacteria.
12/26/2006US7153825 Administering an exendin modified with a polyethylene glycol, gelatin and/or albumin to increase its biological half-life; treating hyperglucagonemia and diabetes, especially type II diabetes
12/26/2006US7153824 Inhibitors of phosphodiesterases in infertility
12/26/2006US7153823 Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease
12/26/2006US7153822 Compositions and methods for modulating connexin hemichannels
12/26/2006US7153683 Present invention relates generally to compositions and methods for modulating activity of MAP/ERK kinase MEK3 and/or other MEK family members; is particularly related to polypeptide variants of TAO proteins
12/26/2006US7153678 Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof
12/26/2006US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
12/26/2006US7153668 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disoders
12/26/2006US7153664 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory disorders
12/26/2006US7153662 Inflammation-specific peptides and the uses thereof
12/26/2006US7153661 Artificial antibody polypeptides
12/26/2006US7153659 Bioassay for measuring the proliferation of T-cells in Human papiloma virus
12/26/2006US7153657 Detecting cell proliferation disorders of lung, liver and/or pancreas which are associated with tumor suppressor lung cancer 1 polypeptide (TSLC1)
12/26/2006US7153529 Administering hemagglutinins
12/26/2006US7153522 bases comprising isoprene-styrene block copolymer and/or polyisobutylene, softeners and tackifier resins, hexylene glycol and 1-menthol as skin absorption intensifiers, and hormones as the drug components
12/26/2006US7153519 Implantable substrate coated with a macromer having free radical polymerizable substituents
12/26/2006US7153515 Method of preventing T cell-mediated responses by the use of the major histocompatibility complex class II analog protein (map protein) from Staphylococcus aureus
12/26/2006US7153514 Use of botulinum toxin therapy for prostatic hyperplasia and related disorders
12/26/2006US7153508 Treatment of B cell lymphoma using anti-CD80 antibodies that do not inhibit the binding of CD80 to CTLA-4
12/26/2006US7153505 Degrading extracellular collogen or elastin of obstructing tissue by administering a collagenase, elastase or trypsin inhibitor to dissolve and remove; softening the remaining tissue, balloon dilation at lower pressures in less mechanical trauma; deblocking artery, vein, ureteter, bronchi, bile duct
12/26/2006US7153504 animal feed additives comprising blends of biological organs, soy hulls and proenzymes, having stability in air and water
12/26/2006US7153503 Comprehensive dietary supplement
12/26/2006US7153499 Promoting differentiation and maturation of immature dendritic cells in a regional lymph node (especially by administering a natural cytokine mixture parilymphatically) so that the cells deliver T-cell antigen to effect immunization
12/21/2006WO2006135846A2 Methods and systems for neural maintenance and regeneration
12/21/2006WO2006135811A2 Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells
12/21/2006WO2006135783A2 Compositions and methods for modulating angiogenesis
12/21/2006WO2006135762A1 Identification of a folliculin-binding protein fnip1
12/21/2006WO2006135740A1 Pegylated hemoglobin and albumin and uses thereof
12/21/2006WO2006135739A2 A novel conotoxin framework with a helix-loop-helix fold
12/21/2006WO2006135733A2 Modulation of peripheral clocks in adipose tissue
12/21/2006WO2006135660A2 Therapies involving lymphotoxin beta receptor
12/21/2006WO2006135506A2 Compositions for topical enzymatic debridement
12/21/2006WO2006135493A2 A composition for wound healing and use thereof
12/21/2006WO2006135385A2 Antagonizing interleukin-21 receptor activity
12/21/2006WO2006135345A1 Phospholipase(s) and use(s) thereof
12/21/2006WO2006135176A1 Human granulocyte-colony stimulating factor isoforms
12/21/2006WO2006135109A1 Method for treatment of proliferative disease utilizing inhibition of formation of synoviolin homooligomer
12/21/2006WO2006135027A1 Agent for treatment of wound and/or promotion of wound healing
12/21/2006WO2006134692A1 Angiogenetic agent containing adrenomedulin as the active ingredient
12/21/2006WO2006134601A2 Methods for the treatment of renal failure
12/21/2006WO2006134340A2 Oxyntomodulin analogues and their effects on feeding behaviour
12/21/2006WO2006134280A2 Mutated nucleotide sequences of the hepatitis c virus
12/21/2006WO2006133955A1 Adamts13-comprising compositions having thrombolytic activity
12/21/2006WO2006133931A2 Identification of jak/stat pathway modulating genes by genome wide rnai screening
12/21/2006WO2006133853A1 Heterodimeric peptide compounds displaying ngf activity and their use to treat neurodegenerative disorders
12/21/2006WO2006133691A1 Method for determining and influencing the fertility of male mammals and of a human being
12/21/2006WO2006133566A1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF
12/21/2006WO2006133553A1 Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins